AtriCure director Regina E. Groves sold 5,313 shares at $54.22 per share, representing about 13.3% of her prior holding. She retained 34,546 AtriCure shares after the transaction, giving investors a clear view of the director’s remaining ownership following the sale.

Key Highlights

  • The transaction occurred on September 11, 2026, under transaction code S.
  • Regina E. Groves held 34,546 AtriCure shares after the sale.
  • The transaction represented about 13.3% of her prior shareholding.

AtriCure, Inc. (NASDAQ: ATRC) director Regina E. Groves sold 5,313 shares at $54.22 per share, representing about 13.3% of her prior holding. Groves retained 34,546 AtriCure shares after the transaction.

September 11 Director Stock Sale

The transaction took place on September 11, 2026, and identified Groves as a director of AtriCure. The filing lists SEC transaction code S for the sale. The reported price was $54.22 for each share transferred. AtriCure’s director transaction involved 5,313 shares. The disclosure identifies Regina E. Groves as the individual conducting the sale. The transaction was reported through the company’s official regulatory disclosure. Transaction code S denotes an open-market or private sale.